Business Description
Addex Therapeutics Ltd
ISIN : CH0029850754
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 76.23 | |||||
Equity-to-Asset | 0.91 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -39.57 | |||||
Beneish M-Score | 34.92 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -45.4 | |||||
3-Year EBITDA Growth Rate | 33.3 | |||||
3-Year EPS without NRI Growth Rate | 33.3 | |||||
3-Year FCF Growth Rate | 38.3 | |||||
3-Year Book Growth Rate | -74.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 49.74 | |||||
9-Day RSI | 47.66 | |||||
14-Day RSI | 46.12 | |||||
6-1 Month Momentum % | -5.98 | |||||
12-1 Month Momentum % | 26.34 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.59 | |||||
Quick Ratio | 4.59 | |||||
Cash Ratio | 3.78 | |||||
Days Sales Outstanding | 194.14 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -66.5 | |||||
Shareholder Yield % | 2.47 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -1995.86 | |||||
Net Margin % | 973.87 | |||||
FCF Margin % | -1076.4 | |||||
ROE % | 98.53 | |||||
ROA % | 67.59 | |||||
ROIC % | -276.65 | |||||
ROC (Joel Greenblatt) % | -7907.5 | |||||
ROCE % | -220.64 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | N/A | |||||
Price-to-Owner-Earnings | 1.75 | |||||
PS Ratio | 14.45 | |||||
PB Ratio | 0.67 | |||||
Price-to-Tangible-Book | 0.64 | |||||
EV-to-EBIT | -0.32 | |||||
EV-to-EBITDA | -0.34 | |||||
EV-to-Revenue | 7.39 | |||||
EV-to-Forward-Revenue | 5.13 | |||||
EV-to-FCF | -0.69 | |||||
Price-to-Net-Current-Asset-Value | 2.89 | |||||
Price-to-Net-Cash | 2.89 | |||||
Earnings Yield (Greenblatt) % | -312.5 | |||||
FCF Yield % | -80.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Addex Therapeutics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil CHF) | 0.555 | ||
EPS (TTM) (CHF) | 0 | ||
Beta | 4.08 | ||
Volatility % | 103.01 | ||
14-Day RSI | 46.12 | ||
14-Day ATR (CHF) | 0.005761 | ||
20-Day SMA (CHF) | 0.0589 | ||
12-1 Month Momentum % | 26.34 | ||
52-Week Range (CHF) | 0.042 - 0.26 | ||
Shares Outstanding (Mil) | 128.27 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Addex Therapeutics Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Addex Therapeutics Ltd Stock Events
Event | Date | Price(CHF) | ||
---|---|---|---|---|
No Event Data |
Addex Therapeutics Ltd Frequently Asked Questions
What is Addex Therapeutics Ltd(XSWX:ADXN)'s stock price today?
When is next earnings date of Addex Therapeutics Ltd(XSWX:ADXN)?
Does Addex Therapeutics Ltd(XSWX:ADXN) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |